News Detail
Copenhagen, 9 Dec 2020: Cancer patients who took immune therapies such as Merck & Co.’s Keytruda or Bristol-Myers Squibb Co.’s Opdivo showed a greater risk of developing heart problems in a View Details
Source : Hindustan Times
Related News
- IIT team shows way for effective drugs to treat HIV/AIDS (19-02-2021)
- Covid deaths 5 times higher in kidney transplant recipients, reveals study (17-02-2021)
- Zinc and Vitamin C neither shortens COVID-19 duration nor alleviates symptoms: Study (16-02-2021)
- Protein behind corona’s slow Asia spread: Study (09-02-2021)
- IIT Madras Researchers Develop Paper-Based Sensors To Detect Antimicrobial Resistance & Pollutants (09-02-2021)
- Antiviral drug thapsigargin effective against Covid, suggests study (06-02-2021)
- Oxford/AstraZeneca rst jab cuts COVID transmission substantially: UK study (04-02-2021)
- Cholesterol increases Covid-19 infectivity: Study (02-02-2021)
- Bharat Biotech’s Covaxin neutralises UK strain of coronavirus: Study (28-01-2021)
- Which masks give you the best protection? (13-12-2020)